Cargando…
Abstract 33: Understanding the Role of Adipocytes and the Tumor Microenvironment on Doxorubicin Therapy of Breast Cancer in a Tissue Engineered, Patient Specific, High-throughput Biomimetic Platform
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504438/ http://dx.doi.org/10.1097/01.GOX.0000558307.97510.a9 |
| _version_ | 1783416579169452032 |
|---|---|
| author | Lara, Daniel Celie, Karel-Bart Toyoda, Yoshiko Wright, Matthew Samadi, Arash Buro, Justin Oshchepkova, Sofya Hameedi, Sophia Brown, Kristy Spector, Jason |
| author_facet | Lara, Daniel Celie, Karel-Bart Toyoda, Yoshiko Wright, Matthew Samadi, Arash Buro, Justin Oshchepkova, Sofya Hameedi, Sophia Brown, Kristy Spector, Jason |
| author_sort | Lara, Daniel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6504438 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Wolters Kluwer Health |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-65044382019-05-29 Abstract 33: Understanding the Role of Adipocytes and the Tumor Microenvironment on Doxorubicin Therapy of Breast Cancer in a Tissue Engineered, Patient Specific, High-throughput Biomimetic Platform Lara, Daniel Celie, Karel-Bart Toyoda, Yoshiko Wright, Matthew Samadi, Arash Buro, Justin Oshchepkova, Sofya Hameedi, Sophia Brown, Kristy Spector, Jason Plast Reconstr Surg Glob Open PSRC 2019 Abstract Supplement Wolters Kluwer Health 2019-04-29 /pmc/articles/PMC6504438/ http://dx.doi.org/10.1097/01.GOX.0000558307.97510.a9 Text en Copyright © 2019 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | PSRC 2019 Abstract Supplement Lara, Daniel Celie, Karel-Bart Toyoda, Yoshiko Wright, Matthew Samadi, Arash Buro, Justin Oshchepkova, Sofya Hameedi, Sophia Brown, Kristy Spector, Jason Abstract 33: Understanding the Role of Adipocytes and the Tumor Microenvironment on Doxorubicin Therapy of Breast Cancer in a Tissue Engineered, Patient Specific, High-throughput Biomimetic Platform |
| title | Abstract 33: Understanding the Role of Adipocytes and the Tumor Microenvironment on Doxorubicin Therapy of Breast Cancer in a Tissue Engineered, Patient Specific, High-throughput Biomimetic Platform |
| title_full | Abstract 33: Understanding the Role of Adipocytes and the Tumor Microenvironment on Doxorubicin Therapy of Breast Cancer in a Tissue Engineered, Patient Specific, High-throughput Biomimetic Platform |
| title_fullStr | Abstract 33: Understanding the Role of Adipocytes and the Tumor Microenvironment on Doxorubicin Therapy of Breast Cancer in a Tissue Engineered, Patient Specific, High-throughput Biomimetic Platform |
| title_full_unstemmed | Abstract 33: Understanding the Role of Adipocytes and the Tumor Microenvironment on Doxorubicin Therapy of Breast Cancer in a Tissue Engineered, Patient Specific, High-throughput Biomimetic Platform |
| title_short | Abstract 33: Understanding the Role of Adipocytes and the Tumor Microenvironment on Doxorubicin Therapy of Breast Cancer in a Tissue Engineered, Patient Specific, High-throughput Biomimetic Platform |
| title_sort | abstract 33: understanding the role of adipocytes and the tumor microenvironment on doxorubicin therapy of breast cancer in a tissue engineered, patient specific, high-throughput biomimetic platform |
| topic | PSRC 2019 Abstract Supplement |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504438/ http://dx.doi.org/10.1097/01.GOX.0000558307.97510.a9 |
| work_keys_str_mv | AT laradaniel abstract33understandingtheroleofadipocytesandthetumormicroenvironmentondoxorubicintherapyofbreastcancerinatissueengineeredpatientspecifichighthroughputbiomimeticplatform AT celiekarelbart abstract33understandingtheroleofadipocytesandthetumormicroenvironmentondoxorubicintherapyofbreastcancerinatissueengineeredpatientspecifichighthroughputbiomimeticplatform AT toyodayoshiko abstract33understandingtheroleofadipocytesandthetumormicroenvironmentondoxorubicintherapyofbreastcancerinatissueengineeredpatientspecifichighthroughputbiomimeticplatform AT wrightmatthew abstract33understandingtheroleofadipocytesandthetumormicroenvironmentondoxorubicintherapyofbreastcancerinatissueengineeredpatientspecifichighthroughputbiomimeticplatform AT samadiarash abstract33understandingtheroleofadipocytesandthetumormicroenvironmentondoxorubicintherapyofbreastcancerinatissueengineeredpatientspecifichighthroughputbiomimeticplatform AT burojustin abstract33understandingtheroleofadipocytesandthetumormicroenvironmentondoxorubicintherapyofbreastcancerinatissueengineeredpatientspecifichighthroughputbiomimeticplatform AT oshchepkovasofya abstract33understandingtheroleofadipocytesandthetumormicroenvironmentondoxorubicintherapyofbreastcancerinatissueengineeredpatientspecifichighthroughputbiomimeticplatform AT hameedisophia abstract33understandingtheroleofadipocytesandthetumormicroenvironmentondoxorubicintherapyofbreastcancerinatissueengineeredpatientspecifichighthroughputbiomimeticplatform AT brownkristy abstract33understandingtheroleofadipocytesandthetumormicroenvironmentondoxorubicintherapyofbreastcancerinatissueengineeredpatientspecifichighthroughputbiomimeticplatform AT spectorjason abstract33understandingtheroleofadipocytesandthetumormicroenvironmentondoxorubicintherapyofbreastcancerinatissueengineeredpatientspecifichighthroughputbiomimeticplatform |